Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Celsion Corp (CLSN)

Celsion Corp (CLSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Celsion Corp 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 USA

www.celsion.com P: 609-896-9100

Description:

Celsion is dedicated to the development and commercialization of oncology drugs including tumor-targeting treatments using focused heat energy in combination with heat activated drug delivery systems. Celsion has research, license or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, North Shore Long Island Jewish Health System.

Key Statistics

Overview:

Market Capitalization, $K 13,913
Enterprise Value, $K -29,627
Shares Outstanding, K 7,099
Annual Sales, $ 500 K
Annual Net Income, $ -20,770 K
Last Quarter Sales, $ 130 K
Last Quarter Net Income, $ -6,040 K
60-Month Beta 2.27
% of Insider Shareholders 4.66%
% of Institutional Shareholders 12.97%
Float, K 6,768
% Float 95.34%
Short Volume Ratio 0.47

Growth:

1-Year Return -87.19%
3-Year Return -91.83%
5-Year Return -91.29%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 97.66%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.87 on 08/15/22
Latest Earnings Date N/A
Earnings Per Share ttm -3.59
EPS Growth vs. Prev Qtr 52.20%
EPS Growth vs. Prev Year 3.28%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 03/01/22

CLSN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -50.18%
Return-on-Assets % -36.94%
Profit Margin % -4,154.00%
Debt/Equity 0.13
Price/Sales 27.83
Price/Cash Flow N/A
Price/Book 0.30
Book Value/Share 6.63
Interest Coverage -37.86
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar